PubMed

Animal models of attention-deficit hyperactivity disorder.

Russell VA, Sagvolden T, Johansen EB.

Behav Brain Funct. 2005 Jul 15;1:9.PMID: 16022733 [PubMed]Related articlesFree article

Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

Russell VA.

Behav Brain Res. 2002 Mar 10;130(1-2):191-6. Review.PMID: 11864734 [PubMed - indexed for MEDLINE]Related articles

Reprint of "Neurobiology of animal models of attention-deficit hyperactivity disorder".

Russell VA.

J Neurosci Methods. 2007 Nov 30;166(2):I-XIV. Review.PMID: 17980763 [PubMed - indexed for MEDLINE]Related articles

Neurobiology of animal models of attention-deficit hyperactivity disorder.

Russell VA.

J Neurosci Methods. 2007 Apr 15;161(2):185-98. Epub 2006 Dec 21. Review. Corrected and republished in: J Neurosci Methods. 2007 Nov 30;166(2):I-XIV. PMID: 17275916 [PubMed - indexed for MEDLINE]Related articles

Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.

Viggiano D, Ruocco LA, Arcieri S, Sadile AG.

Neural Plast. 2004;11(1-2):133-49. Review.PMID: 15303310 [PubMed - indexed for MEDLINE]Related articlesFree article

The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).

Sagvolden T.

Behav Brain Funct. 2006 Dec 15;2:41.PMID: 17173664 [PubMed]Related articlesFree article

Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Mehler-Wex C, Riederer P, Gerlach M.

Neurotox Res. 2006 Dec;10(3-4):167-79. Review.PMID: 17197367 [PubMed - indexed for MEDLINE]Related articles

Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Arnsten AF.

J Clin Psychiatry. 2006;67 Suppl 8:7-12. Review.PMID: 16961424 [PubMed - indexed for MEDLINE]Related articles

Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling.

Viggiano D, Vallone D, Sadile A.

Neural Plast. 2004;11(1-2):97-114. Review.PMID: 15303308 [PubMed - indexed for MEDLINE]Related articlesFree article

Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat.

Russell VA.

Neurosci Biobehav Rev. 2003 Nov;27(7):671-82. Review.PMID: 14624811 [PubMed - indexed for MEDLINE]Related articles

Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes.

Johansen EB, Aase H, Meyer A, Sagvolden T.

Behav Brain Res. 2002 Mar 10;130(1-2):37-45. Review.PMID: 11864716 [PubMed - indexed for MEDLINE]Related articles

Behavioural characterisation of the effects of acute and repeated administration of GBR 12909 in rats: further evaluation of a potential model of ADHD.

Hewitt KN, Marsden CA, Hollis CP, Fone KC.

Neuropharmacology. 2009 Dec;57(7-8):678-86. Epub 2009 Aug 21.PMID: 19699754 [PubMed - indexed for MEDLINE]Related articles

Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).

Oades RD.

Prog Brain Res. 2008;172:543-65. Review.PMID: 18772050 [PubMed - indexed for MEDLINE]Related articles

In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

Nikolaus S, Antke C, Müller HW.

Behav Brain Res. 2009 Dec 1;204(1):32-66. Epub 2009 Jun 10. Review.PMID: 19523495 [PubMed - indexed for MEDLINE]Related articles

Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.

Soeters HS, Howells FM, Russell VA.

Metab Brain Dis. 2008 Sep;23(3):303-14. Epub 2008 Jul 30.PMID: 18665438 [PubMed - indexed for MEDLINE]Related articles

The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.

Li Q, Lu G, Antonio GE, Mak YT, Rudd JA, Fan M, Yew DT.

Neurochem Int. 2007 May;50(6):848-57. Epub 2007 Mar 1.PMID: 17395336 [PubMed - indexed for MEDLINE]Related articles

The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.

Oades RD, Sadile AG, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, Johansen EB, Ruocco LA, Russell VA.

Dev Sci. 2005 Mar;8(2):122-31. Review.PMID: 15720370 [PubMed - indexed for MEDLINE]Related articles

Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

van der Kooij MA, Glennon JC.

Neurosci Biobehav Rev. 2007;31(4):597-618. Epub 2007 Jan 23. Review.PMID: 17316796 [PubMed - indexed for MEDLINE]Related articles

Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.

Arnsten AF.

CNS Drugs. 2009;23 Suppl 1:33-41. doi: 10.2165/00023210-200923000-00005. Review.PMID: 19621976 [PubMed - indexed for MEDLINE]Related articles

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. Review.PMID: 18480677 [PubMed - indexed for MEDLINE]Related articles